[Press release] Médecins Sans Frontières: Gilead refuses to sell groundbreaking HIV prevention drug to MSF

Médecins Sans Frontières (MSF) has publicly called on Gilead Sciences to sell its highly effective HIV prevention drug, lenacapavir, directly to MSF for use in its global medical programs. Despite repeated requests, Gilead has refused to supply the drug to MSF, prompting the organization to issue an open letter. This refusal impacts MSF’s ability to provide crucial HIV prevention in areas where it operates.